Carisma Therapeutics Inc. Payments for Restructuring
Carisma Therapeutics Inc. reported Payments for Restructuring of $1.50 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2023-02-28
- Carisma Therapeutics Inc. payments for restructuring for the quarter ending 2022-12-31 was -$3.08M, a 197.17% decline year-over-year.
- Carisma Therapeutics Inc. payments for restructuring for the quarter ending 2022-09-30 was $3.48M.
- Carisma Therapeutics Inc. payments for restructuring for the quarter ending 2022-06-30 was $596.00K.
- Carisma Therapeutics Inc. payments for restructuring for the quarter ending 2022-03-31 was $507.00K.
- Carisma Therapeutics Inc. payments for restructuring for fiscal 2022 was $1.50M, a 62.86% decline from fiscal 2021.
- Carisma Therapeutics Inc. payments for restructuring for fiscal 2021 was $4.03M.
- Carisma Therapeutics Inc. payments for restructuring for fiscal 2018 was $111.00K, a 23.33% increase from fiscal 2017.
- Carisma Therapeutics Inc. payments for restructuring for fiscal 2017 was $90.00K, a 4614.51% increase from fiscal 2016.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $394.00K derived: sum of 2 quarters · filed 2023-02-28 | $990.00K derived: sum of 3 quarters · filed 2023-02-28 | $1.50M 10-K · filed 2023-02-28 |
| 2022-09-30 | $3.48M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-07 | $4.08M derived: sum of 2 quarters · filed 2022-11-07 | $4.58M 10-Q · filed 2022-11-07 | $7.76M derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-06-30 | $596.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-08-25 | $1.10M 10-Q/A · filed 2022-08-25 | $4.28M derived: sum of 3 quarters · filed 2022-08-25 | |
| 2022-03-31 | $507.00K 10-Q · filed 2022-05-09 | $3.68M derived: sum of 2 quarters · filed 2022-05-09 | ||
| 2021-12-31 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $4.03M 10-K · filed 2022-02-28 | ||
| 2021-09-30 | $856.00K 10-Q · filed 2021-11-08 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $7.00K derived: sum of 2 quarters · filed 2019-03-01 | $58.00K derived: sum of 3 quarters · filed 2019-03-01 | $111.00K 10-K · filed 2019-03-01 |
| 2018-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $58.00K derived: sum of 2 quarters · filed 2018-11-09 | $111.00K 10-Q · filed 2018-11-09 | $173.00K derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-06-30 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $104.00K 10-Q · filed 2018-08-14 | $166.00K derived: sum of 3 quarters · filed 2018-08-14 | |
| 2018-03-31 | $53.00K 10-Q · filed 2018-05-15 | $115.00K derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2017-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $90.00K 10-K · filed 2018-04-02 | ||
| 2017-09-30 | $28.00K 10-Q · filed 2017-11-17 | |||
| 2016-12-31 | $1.91K 10-K · filed 2017-03-24 | |||
| 2016-09-30 | $1.41B 10-Q · filed 2016-11-14 | |||
| 2016-06-30 | $0.00 10-Q · filed 2016-11-14 |